Marit Otterlei
Founder at APIM Therapeutics AS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Asgeir J. Sørensen | M | - |
Norwegian University of Science & Technology
| 6 years |
| Øystein Hov | M | - |
The Norwegian Academy of Science & Letters
 The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Ole Mathias Sejersted | M | 77 |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | 26 years |
| Erlend Petter Skagseth | M | 69 |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Berit Johansen | M | 66 |
Norwegian University of Science & Technology
| 4 years |
| Anders Elverhøi | M | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Johan Einar Hustad | M | 70 |
Norwegian University of Science & Technology
| - |
| Mari-Ann Einarsrud | M | - |
Norwegian University of Science & Technology
| - |
| Kjell Wiik | M | - |
Norwegian University of Science & Technology
| - |
| Stener Kvinnsland | M | 76 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Hans Olav Minsås | M | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Maria Letizia Jaccheri | M | 59 |
Norwegian University of Science & Technology
| 22 years |
| Lise Øvreås | F | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Camilla Serck-Hanssen | F | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Bjørn Fuglaas | M | 65 |
Norwegian University of Science & Technology
| - |
| Gunn Elisabeth Birkelund | F | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Dag L. Aksnes | M | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Hans Petter Graver | M | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Kenneth Ruud | M | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Thomas Jelle | M | 45 |
Norwegian University of Science & Technology
| - |
| Gökhan Batur | M | 42 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | 2 years |
| Randi Eidsmo Reinertsen | F | 74 |
Norwegian University of Science & Technology
| - |
| Hanne Rønneberg | F | 65 |
Norwegian University of Science & Technology
| - |
| Bjørn Hafskjold | M | - |
Norwegian University of Science & Technology
| - |
| Arne Tyssø | M | - |
Norwegian University of Science & Technology
| - |
| Kjell Arne Ingebrigtsen | M | 87 |
Norwegian University of Science & Technology
| - |
| Nils Kristian Nakstad | M | - |
Norwegian University of Science & Technology
| 4 years |
| Nina Udnes Tronstad | F | 65 |
Norwegian University of Science & Technology
| - |
| Jonathan Kearsey | M | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Mona Elisabeth Møller | M | 75 |
Norwegian University of Science & Technology
| - |
| Farzaad Abdi-Dezfuli | M | 61 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Kjetil Taskén | M | 59 |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Ketil Bø | M | 84 |
Norwegian University of Science & Technology
| - |
| Kathrine Skretting | F | - |
Norwegian University of Science & Technology
| - |
| Tor Grande | M | 61 |
Norwegian University of Science & Technology
| - |
| James Lorens | M | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Konstantinos Alevizopoulos | M | 54 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Christos Stylianos Zerefos | M | 81 |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | - |
| Steinar Bjørnstad | M | 58 |
Norwegian University of Science & Technology
| - |
| Jørgen André Nilsen | M | 58 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
| Martin Welschof | M | 63 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | 9 years |
| Birgitte Gangmark Villmo | F | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Christian Lønstad | M | 64 |
Norwegian University of Science & Technology
| 8 years |
| Unni Merete Steinsmo | M | 70 |
Norwegian University of Science & Technology
| 4 years |
| Tore Marken | M | 54 |
Norwegian University of Science & Technology
| 4 years |
| Martha Kold Bakkevig | M | 61 |
Norwegian University of Science & Technology
| 5 years |
| Per Egil Skåre | M | - |
Norwegian University of Science & Technology
| 8 years |
| Lars Sevald Skaare | M | 63 |
Norwegian University of Science & Technology
| 3 years |
| Åse Wikshåland | F | 65 |
Norwegian University of Science & Technology
| 1 years |
| Henrik Badin | M | 55 |
Norwegian University of Science & Technology
| 1 years |
| Knud Hans Nørve | M | 60 |
Norwegian University of Science & Technology
| 1 years |
| Anne Kristin Holmeide | M | 56 |
Norwegian University of Science & Technology
| 1 years |
| Inge Sundet | M | 61 |
Norwegian University of Science & Technology
| 1 years |
| Kristin Gjertsen | F | 55 |
Norwegian University of Science & Technology
| 1 years |
| Kjell-Erik Østdahl | M | 60 |
Norwegian University of Science & Technology
| 1 years |
| Asgeir Wien | F | 58 |
Norwegian University of Science & Technology
| 1 years |
| Berit Osnes | F | 60 |
Norwegian University of Science & Technology
| 1 years |
| Berit Svendsen | F | 61 |
Norwegian University of Science & Technology
| 1 years |
| Torlaug Lode | F | 55 |
Norwegian University of Science & Technology
| 1 years |
| Tove Andersen | F | 54 |
Norwegian University of Science & Technology
| 1 years |
| Knut Bredahl | M | 51 |
Norwegian University of Science & Technology
| 4 years |
| Tom-Erik Lia | M | - |
Norwegian University of Science & Technology
| 1 years |
| Johan Jebsen | M | - |
Norwegian University of Science & Technology
| 5 years |
| Inge Grubben-Strømnes | M | 49 |
Norwegian University of Science & Technology
| 3 years |
| Lars Eirik Ulseth | M | - |
Norwegian University of Science & Technology
| 4 years |
| Morten Longum | M | - |
Norwegian University of Science & Technology
| 4 years |
| Trond Riiber Knudsen | M | 60 |
Norwegian University of Science & Technology
| 1 years |
| Wen Yan Xie | M | 60 |
Norwegian University of Science & Technology
| 2 years |
| Pål Sjåtil | M | - |
Norwegian University of Science & Technology
| 4 years |
| Ørjan Jentoft | M | - |
Norwegian University of Science & Technology
| 1 years |
| Mikael Oerum | M | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | 2 years |
| Even Selnæs | M | - |
Norwegian University of Science & Technology
| 4 years |
| Christel Elise Borge | F | 57 |
Norwegian University of Science & Technology
| 1 years |
| Tore Henrik Guldbrandsøy | M | 60 |
Norwegian University of Science & Technology
| 11 years |
| Olav Egeland | M | - |
Norwegian University of Science & Technology
| 3 years |
| Haakon Bryhni | M | 56 |
Norwegian University of Science & Technology
| 1 years |
| Erik Aas | M | 57 |
Norwegian University of Science & Technology
| 1 years |
| Marit Liland Sandvold | M | 66 |
Norwegian University of Science & Technology
| 3 years |
| Janne Tvedt Morstøl | F | 56 |
Norwegian University of Science & Technology
| 4 years |
| Christian Melby | M | 50 |
Norwegian University of Science & Technology
| 5 years |
| Espen Fjogstad | M | 60 |
Norwegian University of Science & Technology
| 1 years |
| John Olaf Rømma | M | 54 |
Norwegian University of Science & Technology
| 1 years |
| Anjela Gjøs | F | 65 |
Norwegian University of Science & Technology
| 3 years |
| Helge Hellebust | M | 58 |
Norwegian University of Science & Technology
| 1 years |
| Bjarte Håtveit | M | - |
Norwegian University of Science & Technology
| 1 years |
| Bjørn Tore Anfinsen | M | - |
Norwegian University of Science & Technology
| 1 years |
| John Raaum | M | - |
Norwegian University of Science & Technology
| 1 years |
| Svein Helge Guldteig | M | 64 |
Norwegian University of Science & Technology
| 1 years |
| Eystein Borgen | M | - |
Norwegian University of Science & Technology
| 1 years |
| Håkon Borgen | M | - |
Norwegian University of Science & Technology
| 1 years |
| Pål Bruu | M | 45 |
Norwegian University of Science & Technology
| 4 years |
| Per A. Schøyen | M | - |
Norwegian University of Science & Technology
| 1 years |
| Ingvar Straume | M | 63 |
Norwegian University of Science & Technology
| 4 years |
| Tor Kim Steinsland | M | 55 |
Norwegian University of Science & Technology
| 1 years |
| Arne Kjørsvik | M | - |
Norwegian University of Science & Technology
| 1 years |
| Monica Havskjold | M | 62 |
Norwegian University of Science & Technology
| 3 years |
| Eivind Andersen | M | 61 |
Norwegian University of Science & Technology
| 1 years |
| Nils Andreas Thommesen | M | - |
Norwegian University of Science & Technology
| 1 years |
| Erling Woods | M | - |
Norwegian University of Science & Technology
| 3 years |
| Arne Løftingsmo | M | - |
Norwegian University of Science & Technology
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marit Otterlei
- Personal Network
